Location:Room Vienna (Hall B2, level 0)
Novel oncogenic and tumour suppressive miRNA have been discovered in prostate cancer. Recent studies focused on identification of their targets and regulation of cellular events. In this session, signaling pathways regulated by miRNA and androgen receptors in cancerous prostate will be discussed.
- Poster viewing of 20 minutes. Presentations will take place on stage. Standard presentations are 2 minutes in length, followed by 2 minutes for discussion.
Institutes: 1Akita University School of Medicine, Dept. of Urology, Aktia, Japan, 2Akita University School of Medicine, Dept. of Molecular Pathology and Tumor Pathology, Aktia, Japan, 3Akita University Hospital, Dept. of Center For Kidney Disease and Transplantation, Aktia, Japan
Institutes: 1Hirosaki University Graduate School of Medicine, Dept. of Advanced Transplantation & Regenerative Medicine, Hirosaki, Japan, 2Hirosaki University Graduate School of Medicine, Dept. of Urology, Hirosaki, Japan, 3Sanford-Burnham Prebys Medical Discovery Institute, Dept. of Tumor Microenvironment Program, La Jolla, United States of America
Institutes: 1Bond University, Dept. of Urology Research, Gold Coast, Australia, 2Griffith University, School of Pharmacy, Gold Coast, Australia, 3Genesis CancerCare, Dept. of Radiation Oncology, Gold Coast, Australia